PrimeX News

Soft CPI Unlikely to Fuel a Lasting Gold Rally
Fri, 10 Jul 2026 17:46:18 GMT
Gold (XAUUSD), Silver, Platinum Forecasts – Gold Pulls Back As Traders Focus On Rising Treasury Yields
Fri, 10 Jul 2026 17:18:49 GMT
The Oil Trade Most Traders Are Getting Wrong in 2026
Fri, 10 Jul 2026 16:56:27 GMT
U.S. Dollar Pulls Back As Traders Focus On Potential De-Escalation In The Middle East: Analysis For EUR/USD, GBP/USD, USD/CAD, USD/JPY
Fri, 10 Jul 2026 16:23:39 GMT
Nasdaq and S&P500: Meta Leads as Chip Stocks Slide at Mid-Session
Fri, 10 Jul 2026 16:02:13 GMT
Neurocrine Shares Hit Highs on Sales Spike, Strong Pipeline
Fri, 10 Jul 2026 15:58:48 GMT

From Currencies to Commodities: Leveraging Gold Ratios in Trading
Thu, 25 Jun 2026 12:59:13 GMT
First Light News: Trump Puts Pen to Paper & the Fed Comes in Hawkish
Thu, 18 Jun 2026 08:20:37 GMT
ECB, Bank of England Set to Hold Rates Unchanged Today
Thu, 11 Jun 2026 17:21:35 GMT
Nasdaq 100: Meta Falls as Amazon Slips, Microsoft, Alphabet Diverge
Wed, 29 Apr 2026 21:43:04 GMT
Hungary’s Euro Ambition Is a Long-term Bet Requiring Discipline, Credibility and Integration
Thu, 11 Jun 2026 17:22:50 GMT
A Divided Fed to Continue Favouring Easing Even as the Iran War Raises the Stakes
Thu, 11 Jun 2026 17:20:25 GMT

Seasonality and Event-Driven Trades in ETFs: How to Spot Recurring Trading Opportunities
Fri, 19 Jun 2026 23:26:11 GMT
Building and Risk-Managing Multi-Asset Portfolios with ETFs
Fri, 19 Jun 2026 20:08:58 GMT
What Really Drives ETF Performance: Rebalancing, Dividends, Fees, and Tracking Error
Tue, 23 Jun 2026 13:26:26 GMT
Trading Volume Explained: Why it Matters for Breakouts, Reversals and Trends
Wed, 10 Jun 2026 00:40:01 GMT
RSI Indicator Explained: How to Read Momentum and Time Trades in 2026
Wed, 03 Jun 2026 21:56:39 GMT
Fibonacci Retracements Explained: How to Spot Key Reversal Levels in 2026
Thu, 28 May 2026 12:22:53 GMT

Advertisement

Advertisement

ASND

Ascendis Pharma A/S Ordinary Share

270.01

USD

-5.42

-1.97%

Jul 10, 14:18 UTC -4

Open

ASND News & Forecasts

featured

Zacks Investment Research

Ascendis Pharma (ASND) Moves 9.9% Higher: Will This Strength Last?

featured

Ascendis Pharma: Rare Endocrine Compounder Entering Growth Phase (Initiating Buy)

featured

Ascendis Pharma A/S (ASND) Q1 2026 Earnings Call Transcript

Advertisement

Advertisement

Advertisement